Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$0.42 - $0.72 $160,203 - $274,633
381,436 Added 310.57%
504,255 $317,000
Q3 2023

Nov 14, 2023

SELL
$0.6 - $1.53 $484,745 - $1.24 Million
-807,909 Reduced 86.8%
122,819 $73,000
Q2 2023

Aug 14, 2023

BUY
$1.05 - $1.63 $486,662 - $755,485
463,488 Added 99.2%
930,728 $1.05 Million
Q1 2023

May 15, 2023

BUY
$1.2 - $2.73 $62,182 - $141,465
51,819 Added 12.47%
467,240 $630,000
Q4 2022

Feb 14, 2023

BUY
$1.71 - $3.61 $586,701 - $1.24 Million
343,100 Added 474.41%
415,421 $772,000
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $139,965 - $635,737
-73,666 Reduced 50.46%
72,321 $178,000
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $139,965 - $635,737
-73,666 Reduced 50.46%
72,321 $178,000
Q2 2022

Aug 16, 2022

SELL
$2.13 - $9.01 $343,153 - $1.45 Million
-161,105 Reduced 52.46%
145,987 $357,000
Q1 2022

May 17, 2022

SELL
$6.28 - $15.59 $2 Million - $4.96 Million
-318,001 Reduced 50.87%
307,092 $2.45 Million
Q4 2021

Feb 15, 2022

BUY
$14.7 - $28.67 $2.66 Million - $5.18 Million
180,845 Added 40.71%
625,093 $9.55 Million
Q3 2021

Nov 16, 2021

BUY
$24.31 - $33.6 $54,624 - $75,499
2,247 Added 0.51%
444,248 $12.6 Million
Q2 2021

Aug 16, 2021

SELL
$26.09 - $40.4 $6.44 Million - $9.97 Million
-246,662 Reduced 35.82%
442,001 $14.9 Million
Q1 2021

May 18, 2021

BUY
$33.06 - $56.93 $10.3 Million - $17.8 Million
312,800 Added 83.22%
688,663 $26.3 Million
Q4 2020

Feb 17, 2021

BUY
$39.09 - $57.4 $11.7 Million - $17.1 Million
298,176 Added 383.82%
375,863 $15.7 Million
Q3 2020

Nov 17, 2020

BUY
$28.43 - $44.67 $95,553 - $150,135
3,361 Added 4.52%
77,687 $3.37 Million
Q2 2020

Aug 17, 2020

BUY
$11.71 - $30.29 $242,115 - $626,276
20,676 Added 38.54%
74,326 $2.25 Million
Q1 2020

May 15, 2020

SELL
$7.64 - $27.5 $38,291 - $137,830
-5,012 Reduced 8.54%
53,650 $733,000
Q4 2019

Feb 14, 2020

SELL
$15.02 - $20.57 $1.32 Million - $1.81 Million
-88,059 Reduced 60.02%
58,662 $946,000
Q3 2019

Nov 14, 2019

BUY
$18.85 - $27.5 $2.77 Million - $4.03 Million
146,721 New
146,721 $2.83 Million
Q2 2019

Aug 15, 2019

SELL
$17.37 - $26.27 $973,762 - $1.47 Million
-56,060 Closed
0 $0
Q1 2019

May 16, 2019

BUY
$10.65 - $25.75 $597,039 - $1.44 Million
56,060 New
56,060 $1.31 Million
Q4 2018

Feb 15, 2019

SELL
$9.26 - $16.38 $343,268 - $607,206
-37,070 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $279,507 - $678,751
37,070 New
37,070 $620,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.